CURRICULUM VITAE
James H. Jerkins MD
James H. Jerkins MD
Assistant Professor
Department of Medicine
Division of Hematology and Oncology - Medicine
Department of Medicine
Division of Hematology and Oncology - Medicine
OFFICE ADDRESS: |
Froedtert Hospital |
9200 W Wisconsin Ave |
Milwaukee, WI 53226 |
EDUCATION: |
08/1999 - 07/2003 Bachelors of Science, University of Alabama at Birmingham, Birmingham, AL |
08/2003 - 06/2007 Doctorates of Medicine, Loma Linda University, Loma Linda, CA |
07/2016 - 07/2019 Masters in Clinical and Translational Science, Medical College of Wisconsin, Milwaukee, WI |
POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS: |
07/2007 - 06/2010 Resident, Department of Medicine, Kettering Medical Center, Internal Medicine, Kettering, Ohio |
07/2010 - 06/2011 Chief Resident, Department of Medicine, Kettering Medical Center, Kettering, Ohio |
07/2011 - 06/2014 Fellow, Department of Medicine, Division of Hematology/Oncology, University of California Irvine, Irvine, California |
07/2016 - 06/2018 Instructor, Department of Medicine, Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin |
FACULTY APPOINTMENTS: |
07/2010 - 06/2021 Chief Resident, Department of Medicine, Kettering Medical Center, Kettering, OH |
10/2014 - 06/2016 HS Assistant Professor, Department of Medicine, Division of Hematology/Oncology, UC IRvine Medical Center, Irvine, CA |
07/2016 - 06/2018 Instructor, Department of Medicine, Division of Hematology/Oncology, The Medical College of Wisconsin, Milwaukee, WI |
07/2019 - Present Assistant Professor, Department of Medicine, Division of Hematology/Oncology, The Medical College of Wisconsin, Milwaukee, WI |
ADMINISTRATIVE APPOINTMENTS: |
11/2018 - Present Member MCW IRB Committee #3, Medical College of Wisconsin |
02/2021 - Present Vice-Chair MCW IRB Committee #3, Medical College of Wisconsin |
EDUCATIONAL ADMINISTRATIVE APPOINTMENTS: |
07/2020 - Present Course Director, M4 Blood and Marrow Transplantation AI Rotation, Medical College of Wisconsin |
HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS: |
07/2018 - Present Director Adult BMT Long Term Follow-up Clinic, Froedtert Hospital, 9200 W. Wisconsin Ave., Milwaukee, WI 53226 |
05/2019 - Present HPC, Marrow Collections - Adult Medical Director, Medical College of Wisconsin |
HOSPITAL STAFF PRIVILEGES: |
10/2014 - 06/2016 Assistant Professor, Medicine, Hematology/Oncology, University of California, Irvine |
07/2016 - 06/2018 Instructor, Froedtert Memorial Lutheran Hospital, 9200 W. Wisconsin Ave., Milwaukee, WI 53226 |
07/2018 - Present Assistant Professor, Froedtert Memorial Lutheran Hospital, 9200 W. Wisconsin Ave., Milwaukee, WI 53226 |
SPECIALTY BOARDS AND CERTIFICATION: |
Board Certified | Issue Date | Expiration |
American Board of Internal Medicine | 08/2014 | None |
ABIM - Hematology | 10/2015 | None |
ABIM - Oncology | 10/2015 | None |
Licensure | Number | Issue Date | Expiration |
Ohio License | 2010 | 2012 | |
California License | A 117492 | 2011 | 2016 |
Wisconsin License | 65931-20 | 07/19/2016 | 10/31/2023 |
MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES: |
2007 - 2011 American College of Physicians |
2007 - 2011 American Medical Association |
2011 - 2015 American Association for Cancer Research |
2011 - 2015 American Society of Hematology |
2011 - 2015 American Society of Clinical Oncology |
American Society for Transplantation and Cellular Therapy |
RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
INVITED LECTURES/WORKSHOPS/PRESENTATIONS: |
Regional |
J. Jerkins, D. Jeyakumar, Chronic Lymphocytic Leukemia, Case Presentation, Los Angeles Lymphoma Rounds, Los Angeles, California, 04/24/2014 - Present |
J. Jerkins, D. Jeyakumar, Composite Lymphoma, Case Presentation, Los Angeles Lymphoma Rounds, Los Angeles, California, 02/2015 - Present |
PEER REVIEWED WORKSHOPS/PRESENTATIONS: |
International |
Nelson, Maggie, Emilie Aschenbrenner, Aaron Lorge, Anne Daniels, James Jerkins, and Ruta Brazauskas, Risk Factors for Vancomycin-Associated Nephrotoxicity in Hematopoietic Stem Cell Transplant Population, Transplantation & Cellular Therapy Meeting, 02/08/2021 |
Ho, V., Duarte, R.F., Boelens, J.J., Cairo, M.S., Champlin, R.E., Giralt, S., Hamadani, M., Higham, C.S., Jerkins, J.H., Laurence, J. and Mayer, S., METHODOLOGY OF AN INTERNATIONAL MULTI-CENTER RETROSPECTIVE REVIEW OF TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (TA-TMA) BY THE TA-TMA WORKING GROUP, EBMT, 03/22/2022 |
BIBLIOGRAPHY |
Refereed Journal Publications/Original Papers |
1. Jerkins JH, Suciu A, Mazimba S, Calvo A. Bortezomib-induced Severe Congestive Heart Failure. Cardiol Res. 2010 Dec;1(1):20-23. PMCID: PMC5358234 |
2. Raufi A, Jerkins J, Lyou Y, Jeyakumar D. A Patient with Supraclavicular Lymphadenopathy and Anterior Mediastinal Mass Presenting as a Rare Case of Composite Lymphoma: A Case Report and Literature Review. Case Rep Oncol. 2016;9(3):854-860. PMCID: PMC5260532 |
3. Jerkins, James H.
Calvo, Alejandro R.
Shrit, M. Atef. Hemochromatosis in the setting of Chronic Parvovirus B-19 induced Aplastic Anemia. Cancer Therapy.. 2011, Vol. 8, p86-89. 4p.. |
4. Vazirabad I, Chhabra S, Nytes J, Mehra V, Narra RK, Szabo A, Jerkins JH, Dhakal B, Hari P, Anderson MW. Direct HLA Genetic Comparisons Identify Highly Matched Unrelated Donor-Recipient Pairs with Improved Transplantation Outcome. Biol Blood Marrow Transplant. 2019 May;25(5):921-931. |
5. Jerkins JH, Hamadani M, Zook F, Epperla N, Shaw BE, Saber W, Rizzo JD, Pasquini M, Chhabra S, Drobyski WR, Hari PN, Shah NN. Alpha-1-antitrypsin for the treatment of steroid-refractory acute gastrointestinal graft-versus-host disease. Am J Hematol. 2017 Oct;92(10):E610-E611. |
6. Abedin S, McKenna E, Chhabra S, Pasquini M, Shah NN, Jerkins J, Baim A, Runaas L, Longo W, Drobyski W, Hari PN, Hamadani M. Efficacy, Toxicity, and Infectious Complications in Ruxolitinib-Treated Patients with Corticosteroid-Refractory Graft-versus-Host Disease after Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2019 Aug;25(8):1689-1694. |
7. Raj RV, Hamadani M, Szabo A, Pasquini MC, Shah NN, Drobyski WR, Shaw BE, Saber W, Rizzo JD, Jerkins J, Fenske TS, D'Souza A, Dhakal B, Zhang C, Konings S, Hari PN, Chhabra S. Peripheral Blood Grafts for T Cell-Replete Haploidentical Transplantation Increase the Incidence and Severity of Cytokine Release Syndrome. Biol Blood Marrow Transplant. 2018 Aug;24(8):1664-1670. |
8. Chhabra S, Jerkins JH, Conto JE, Zellner K, Shah NN, Hari PN, Hamadani M. Lifitegrast ophthalmic solution for treatment of ocular chronic graft-versus-host disease. Leuk Lymphoma. 2020 Apr;61(4):869-874. |
9. Badar T, Khan MA, Szabo A, Drobyski W, Chhabra S, Dhakal B, Fenske TS, Hamadani M, Hari P, Jerkins JH, Shah NN, Shaw BE, D'Souza A. Incidence and characteristics of engraftment syndrome after autologous hematopoietic cell transplantation in light chain amyloidosis. Amyloid. 2019 Dec;26(4):210-215. |
10. Jerkins JH, Calvo AR, Atef Shrit M. Hemochromatosis in the setting of Chronic Parvovirus B-19 induced Aplastic Anemia Cancer Therapy. 2010;8(ISSUE A):86-89. |
11. Chhabra S, Narra RK, Wu R, Szabo A, George G, Michaelis LC, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Pasquini MC, Rizzo RD, Saber W, Shah NN, Shaw BE, Hamadani M, Hari PN. Fludarabine/Busulfan Conditioning-Based Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: Role of Ruxolitinib in Improving Survival Outcomes. Biol Blood Marrow Transplant. 2020 May;26(5):893-901. |
12. Chhabra S, Thapa B, Szabo A, Konings S, D'Souza A, Dhakal B, Jerkins JH, Pasquini MC, Johnson BD, Hari PN, Hamadani M. Utilization and Cost Implications of Hematopoietic Progenitor Cells Stored for a Future Salvage Autologous Transplantation or Stem Cell Boost in Myeloma Patients. Biol Blood Marrow Transplant. 2020 Nov;26(11):2011-2017. |
13. Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Douglas Rizzo J, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M. Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2020 Oct;26(10):1876-1885. PMCID: PMC7571859 |
14. Shah NN, Jerkins JH, Johnson BD, Hari P. Treatment-Emergent Tumor Lysis Syndrome With PI3Kδ-γ Inhibition After CAR T-Cell Therapy for Chronic Lymphocytic Leukemia. JCO Oncol Pract. 2020 Sep;16(9):613-614. |
15. Abid MB, Hamadani M, Szabo A, Hari PN, Graham MB, Frank MO, Collier WS, Abedin S, Jerkins JH, Pasquini MC, Runaas L, Shah NN, Chhabra S. Severity of Cytokine Release Syndrome and Its Association with Infections after T Cell-Replete Haploidentical Related Donor Transplantation. Biol Blood Marrow Transplant. 2020 Sep;26(9):1670-1678. |
16. Murthy GSG, Jerkins J, Knight J. Capsule Commentary on Zheng et al., The Role of Spirituality in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Mixed Studies Review. J Gen Intern Med. 2020 Jul;35(7):2253. PMCID: PMC7351970 |
17. Juhasz M, Laquer V, Jerkins J, Smith J. "Peeling paint" dermatosis in a leukemia patient. JAAD Case Rep. 2020 Apr;6(4):354-356. PMCID: PMC7103659 |
18. Chhabra S, Szabo A, Glisch C, George G, Narra RK, Harrington A, Jerkins JH, D'Souza A, Dhakal B, Pasquini MC, Hamadani M, Hari PN. Relapse after Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma: Survival Outcomes and Factors Influencing Them. Biol Blood Marrow Transplant. 2020 Jul;26(7):1288-1297. |
19. Monahan K, Kleman A, Thapa B, Szabo A, D'Souza A, Dhakal B, Jerkins JH, Pasquini MC, Hamadani M, Hari PN, Chhabra S. Propylene Glycol-Free Melphalan versus PG-Melphalan as Conditioning for Autologous Hematopoietic Cell Transplantation for Myeloma. Biol Blood Marrow Transplant. 2020 Dec;26(12):2229-2236. |
20. Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Rizzo JD, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M. Corrigendum to a??Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantationa?? [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885] (Biology of Blood and Marrow Transplantation (2020) 26/10(1876-1885) (S1083879120304146), (10.1016/j.bbmt.2020.07.005)) Transplantation and Cellular Therapy. 2021. |
21. Chhabra S, Callander N, Watts NL, Costa LJ, Thapa B, Kaufman JL, Laubach J, Sborov DW, Reeves B, Rodriguez C, Chari A, Silbermann R, Anderson LD Jr, Bal S, Dhakal B, Nathwani N, Shah N, Medvedova E, Bumma N, Holstein SA, Costello C, Jakubowiak A, Wildes TM, Schmidt T, Orlowski RZ, Shain KH, Cowan AJ, Dholaria B, Cornell RF, Jerkins JH, Pei H, Cortoos A, Patel S, Lin TS, Usmani SZ, Richardson PG, Voorhees PM. Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma: Findings from the MASTER and GRIFFIN Trials. Transplant Cell Ther. 2023 Mar;29(3):174.e1-174.e10. |
22. Chhabra S, Szabo A, Clurman A, McShane K, Waters N, Eastwood D, Samanas L, Fei T, Armijo G, Abedin S, Longo W, Hari P, Hamadani M, Shah NN, Runaas L, Jerkins JH, Van den Brink M, Peled JU, Drobyski WR. Mitigation of gastrointestinal graft-<i>versus</i>-host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination. Haematologica. 2023 Jan 01;108(1):250-256. PMCID: PMC9827178 |
Editorials, Letters to Editor, Other |
1. Tang R, Jerkins JH, Zhao X, Jeyakumar D., ‘Triple-Hit’ Lymphoma with Rapid “Leukemic” Phase After Resection of Primary Tumor. Presented at 2nd Annual Summit on Practical and Emerging Trends in Lymphoid Malignancies and Multiple Myeloma. March 15, 2015. |
2. The 3' Untranslated Region of the hTERT Gene as a Control Mechanism for Translation, Honors Research Poster Session; Birmingham, AL, July 2003 (with LG Andrews, TO Tollefsbol) |
